SVB Leerink bullish on Oak Street Health, initiates with an Outperform » 08:2609/2409/24/20
As previously reported,…
As previously reported, SVB Leerink analyst Stephen Tanal initiated coverage of Oak Street Health (OSH) with an Outperform rating and $55 price target. The analyst argues that Oak Street Health has built a great business purpose-built to address great societal needs, namely healthcare costs and outcomes for aged, chronically-ill and low-income seniors on Medicare. The end market is massive, which should allow for decades of rapid organic growth, aided by symbiotic relationships with payors and, potentially, Walmart (WMT), alongside the advent of Medicare Direct Contracting, he adds.
Oak Street Health initiated with an Outperform at SVB Leerink » 07:2709/2409/24/20
SVB Leerink initiated…
SVB Leerink initiated coverage of Oak Street Health with an Outperform rating and $55 price target.
|Over a week ago|
Resumed openings lend upside bias to Oak Street guidance, says Piper Sandler » 13:2409/1709/17/20
Piper Sandler analyst…
Piper Sandler analyst Sean Wieland reiterates an Overweight rating and $54 price target for Oak Street Health shares. Wieland says Q2 results were in line with preliminary estimates published in the company's S1 filing, but displayed impressive expansion across key metrics like patients per center, percent of patients at risk and capitated revenue per at risk patient. The analyst believes the resumption of new center openings and patient recruitment efforts lend an upside bias to Q3 and FY20 guidance.
Oak Street Health falls -7.4% » 12:0009/1709/17/20
Oak Street Health is down…
Oak Street Health is down -7.4%, or -$3.07 to $38.44.
Oak Street deal with Walmart an incremental opportunity, says Morgan Stanley » 08:2109/0209/02/20
After Oak Street Health…
After Oak Street Health (OSH) announced it will collaborate with Walmart (WMT) to take over three Walmart Care Clinics in Texas that are being phased out as Walmart is ramping its new Health Clinics, Morgan Stanley analyst Ricky Goldwasser said she sees this as an incremental opportunity for Oak Street to expand share at a lower acquisition cost. While the current partnership agreement is limited to the three Texas clinics, she sees an opportunity for Oak Street to collaborate with Walmart in other markets over time if this is successful, the analyst tells investors. Goldwasser has an Equal Weight rating and $50 price target on Oak Street shares.
Oak Street Health initiated with an Overweight at JPMorgan » 09:0508/3108/31/20
JPMorgan analyst Gary…
JPMorgan analyst Gary Taylor initiated coverage of Oak Street Health with an Overweight rating and $52 price target. The company has redesigned primary care for seniors and has potential to deliver "substantial" clinical, strategic and financial value to seniors, health insurers and the U.S. government, Taylor tells investors in a research note.
Oak Street Health initiated with an Outperform at Baird » 08:1708/3108/31/20
Baird analyst Matthew…
Baird analyst Matthew Gillmor initiated coverage of Oak Street Health with an Outperform rating and $55 price target. The analyst said his positive thesis is based on it tech-enabled platform delivering superior patient experience and lower healthcare costs, its platform design to scale nationally, and its retail focus.
Oak Street Health initiated with a Buy at Truist » 07:4908/3108/31/20
Truist analyst David…
Truist analyst David MacDonald initiated coverage of Oak Street Health with a Buy rating and $56 price target. The analyst is positive on the company's "unique" primary care model that offers "personalized" integrated services seeking to address "meaningful" challenges that include the aging population, chronic disease management, and rising healthcare industry costs. MacDonald adds that Oak Street's Canopy platform creates a "virtuous cycle" as it helps to better inform the care delivery decisions through predictive analytics using data from multiple sources to create a fulsome picture of a patient's medical, behavioral, and social health history.
Oak Street Health initiated with an Outperform at William Blair » 07:0408/3108/31/20
William Blair analyst…
William Blair analyst Ryan Daniels initiated coverage of Oak Street Health with an Outperform rating.
Oak Street Health initiated with an Equal Weight at Morgan Stanley » 06:2408/3108/31/20
Morgan Stanley analyst…
Morgan Stanley analyst Ricky Goldwasser initiated coverage of Oak Street Health with an Equal Weight rating and $50 price target. While the company's has a large addressable market, recurring revenue and margin expansion potential with its differentiated primary care platform for Medicare Advantage members, these positives are largely reflected in the current share price, Goldwasser tells investors.